id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-N-0011-0002,FDA,FDA-2019-N-0011,Office of Regulatory Affairs Division Director; Technical Amendments,Rule,Final Rule,2020-08-18T04:00:00Z,2020,8,2020-08-18T04:00:00Z,,2020-08-24T19:44:24Z,2020-17037,0,0,090000648480cee0
FDA-2019-N-0011-0001,FDA,FDA-2019-N-0011,Office of Regulatory Affairs Division Director; Technical Amendments,Rule,Final Rule,2020-03-24T04:00:00Z,2020,3,2020-03-24T04:00:00Z,,2020-03-24T12:44:29Z,2020-05213,0,0,090000648446364e